Extensively Hydrolyzed Formula and Infant Colic Symptoms: Secondary Analysis of a Prospective Cohort Study

Jerry Mack Brown1, Jessica Victoria Baran1, Luke Lamos1

  • 1Office of Medical Education, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, USA.

Clinical Pediatrics
|March 11, 2024
PubMed

Insights

Healthcare providers prioritize safety, tolerability, and efficacy when selecting alternative extensively hydrolyzed formulas for infants with cow

Area of Science:

  • Pediatric Allergy and Immunology
  • Infant Nutrition
  • Clinical Decision-Making

Background:

  • Cow's milk protein allergy (CMPA) impacts 2-3% of infants, typically managed with specialized hypoallergenic formulas.
  • Recent infant formula recalls and subsequent shortages have complicated CMPA management.
  • Limited research exists on pediatric healthcare providers' (HCPs) decision-making processes during formula shortages.

Purpose of the Study:

  • To investigate the factors influencing HCPs' choices when transitioning infants to alternative extensively hydrolyzed formulas during shortages.
  • To understand the specific considerations pediatric physicians employ when managing CMPA amidst supply chain disruptions.

Main Methods:

  • A de-identified survey was distributed to US-based HCPs.
  • 104 eligible participants included general pediatricians, pediatric allergists/immunologists, and pediatric gastroenterologists.
  • The survey assessed key decision-making drivers for switching extensively hydrolyzed formulas.

Main Results:

  • Safety, tolerability, and efficacy were the primary factors cited by HCPs for formula selection.
  • A specific formula (Formula 1) was consistently reported as well-tolerated, safe, and effective by participants.
  • HCPs expressed strong confidence in Formula 1's safety and efficacy profile.

Conclusions:

  • Findings provide critical insights into HCPs' strategies for managing CMPA during formula shortages.
  • The study highlights the importance of safety, tolerability, and efficacy in guiding formula selection.
  • Recommendations can enhance infant care and support HCPs in navigating formula supply challenges.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Hydrolysis01:15

Hydrolysis

Overview
Hydrolysis is a chemical reaction in which the addition of water breaks down a polymer into its simpler monomer units. For example, peptides break into amino acids, carbohydrates into simple sugars, and DNA into nucleotides. Enzymes often facilitate these processes.
Hydrolysis Reverses Dehydration Synthesis
Complex carbohydrates can be broken down by breaking the bonds between individual sugar units. The reaction breaks a glycosidic bond as water is added to the compound. The...
105.3K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
160
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
163
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
194